Pulmonary blood flow describes the movement of blood through the lungs, facilitating gas exchange and ensuring adequate oxygenation of the systemic circulation. Efficient perfusion of alveolar capillaries is essential for maintaining oxygen delivery to tissues and removal of carbon dioxide. Disruptions in pulmonary blood flow, whether due to vascular obstruction, cardiac dysfunction, or pulmonary hypertension, can compromise oxygenation, increase right ventricular workload, and lead to progressive respiratory compromise. Clinicians evaluate pulmonary blood flow through a combination of imaging and functional assessments. Techniques such as lung perfusion scans, echocardiography, and contrast-enhanced computed tomography provide insights into vascular integrity, perfusion distribution, and the presence of thromboembolic disease. Pulmonary artery catheterization may be employed in complex cases to directly measure pressures and flow dynamics. These diagnostic tools help identify regional perfusion defects, quantify shunting, and assess the impact of structural or functional vascular abnormalities.
Management strategies aim to restore or optimize blood flow while addressing underlying causes. Anticoagulation therapy, thrombolysis, and surgical or catheter-directed interventions are utilized in thromboembolic disorders. In pulmonary hypertension, vasodilators and supportive measures such as oxygen therapy reduce vascular resistance and improve perfusion. Exercise programs and pulmonary rehabilitation can further enhance cardiovascular efficiency. Advances in molecular imaging and computational modeling are expanding the understanding of pulmonary hemodynamics, enabling more precise evaluation and targeted therapy. By integrating diagnostic precision with tailored interventions, optimizing pulmonary blood flow supports effective gas exchange, reduces cardiopulmonary strain, and improves functional outcomes for patients with vascular or respiratory disorders.
Title : Global warming and increasing respiratory illnesses
Yazdan Mirzanejad, University of British Columbia, Canada
Title :
Saurabh Chattopadhyay, University of Kentucky, United States
Title : Risk factors for mycobacterium avium complex infections in patients with chronic obstructive pulmonary disease
Alizaman Sadigov, Medical University, United States
Title : Managing integration and interoperability in transformed pulmonology, respiratory medicine and lung health ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Oncology (PPO) to be set up via precision oncology strategy for cancer care team: Developing targeted lung cancer therapy and advancing personalized cancer care
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Advancements in pulmonology and respiratory care through the view of Personalized and Precision Medicine (PPM) and biodesign-driven translational applications
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation